The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, E.-S.
Right arrow Articles by Iacomini, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, E.-S.
Right arrow Articles by Iacomini, J.
The Journal of Immunology, 2002, 169: 1930-1935.
Copyright © 2002 by The American Association of Immunologists

Induction of Central Deletional T Cell Tolerance by Gene Therapy1

Eun-Suk Kang and John Iacomini2

Transplantation Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129

Transgenic mice expressing an alloreactive TCR specific for the MHC class I Ag Kb were used to examine the mechanism by which genetic engineering of bone marrow induces T cell tolerance. Reconstitution of lethally irradiated mice with bone marrow infected with retroviruses carrying the MHC class I gene H-2Kb resulted in lifelong expression of Kb on bone marrow-derived cells. While CD8 T cells expressing the transgenic TCR developed in control mice reconstituted with mock-transduced bone marrow, CD8 T cells expressing the transgenic TCR failed to develop in mice reconstituted with H-2Kb transduced bone marrow. Analysis of transgene-expressing CD8 T cells in the thymus and periphery of reconstituted mice revealed that CD8 T cells expressing the transgenic TCR underwent negative selection in the thymus of mice reconstituted with Kb transduced bone marrow. Negative selection induced by gene therapy resulted in tolerance to Kb. Thus, genetic engineering of bone marrow can be used to alter T cell education in the thymus by inducing negative selection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
U. Baranyi, B. Linhart, N. Pilat, M. Gattringer, J. Bagley, F. Muehlbacher, J. Iacomini, R. Valenta, and T. Wekerle
Tolerization of a Type I Allergic Immune Response through Transplantation of Genetically Modified Hematopoietic Stem Cells
J. Immunol., June 15, 2008; 180(12): 8168 - 8175.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Tian, M. J. I. Ansari, J. Paez-Cortez, J. Bagley, J. Godwin, M. Donnarumma, M. H. Sayegh, and J. Iacomini
Induction of Robust Diabetes Resistance and Prevention of Recurrent Type 1 Diabetes Following Islet Transplantation by Gene Therapy
J. Immunol., November 15, 2007; 179(10): 6762 - 6769.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Werner-Klein, C. Dresch, P. Marconi, and T. Brocker
Transcriptional Targeting of B Cells for Induction of Peripheral CD8 T Cell Tolerance
J. Immunol., June 15, 2007; 178(12): 7738 - 7746.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Forman, E.-S. Kang, C. Tian, J. Paez-Cortez, and J. Iacomini
Induction of Alloreactive CD4 T Cell Tolerance in Molecular Chimeras: A Possible Role for Regulatory T Cells
J. Immunol., March 15, 2006; 176(6): 3410 - 3416.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Tian, J. Bagley, and J. Iacomini
Expression of Antigen on Mature Lymphocytes Is Required to Induce T Cell Tolerance by Gene Therapy
J. Immunol., October 1, 2002; 169(7): 3771 - 3776.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.